NCT00960180View on ClinicalTrials.gov

Study Evaluating Single Ascending Doses of MR1817

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Adult
Interventions
DRUG

MR1817

DRUG

Placebo

Trial Locations (1)

CB23 2TN

Cambridge

Sponsors
All Listed Sponsors
lead

Mochida Pharmaceutical Company, Ltd.

INDUSTRY